|
PNRC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65512048511118E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.76156916515447E-13 |
| Normal-vs-Stage2 |
2.57605048403775E-12 |
| Normal-vs-Stage3 |
1.62458935193399E-12 |
| Normal-vs-Stage4 |
5.10702591327572E-15 |
| Stage1-vs-Stage2 |
2.648400E-01 |
| Stage1-vs-Stage3 |
7.566600E-04 |
| Stage1-vs-Stage4 |
9.884400E-03 |
| Stage2-vs-Stage3 |
1.895620E-01 |
| Stage2-vs-Stage4 |
2.383800E-01 |
| Stage3-vs-Stage4 |
9.751600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.88578058618805E-15 |
| Normal-vs-AfricanAmerican |
3.50059999998376E-06 |
| Normal-vs-Asian |
8.17479994807968E-09 |
| Caucasian-vs-AfricanAmerican |
8.555500E-02 |
| Caucasian-vs-Asian |
6.443000E-03 |
| AfricanAmerican-vs-Asian |
8.172200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.12243547789603E-13 |
| Normal-vs-Female |
2.63122856836162E-14 |
| Male-vs-Female |
7.027000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.21023199742376E-12 |
| Normal-vs-Age(41-60Yrs) |
1.63002944475465E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(81-100Yrs) |
4.10140000000059E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.567900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.540450E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.703400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.709800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.937800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.539600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.583000000007E-05 |
| Classical-VS-Follicular |
4.906600E-01 |
| Classical-VS-Other |
4.542000E-01 |
| Classical-VS-Normal |
1.18938192628093E-12 |
| Tall-VS-Follicular |
9.84889999999794E-05 |
| Tall-VS-Other |
4.904200E-03 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
6.530600E-01 |
| Follicular-VS-Normal |
3.09885450633374E-12 |
| Other-VS-Normal |
6.683600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.1873835248366E-12 |
| N0-vs-N1 |
6.406200E-01 |
|
|
